Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Is FAST-Forward/ultra-hypofractionation suitable for an early-stage breast patient after a lumpectomy with oncoplastic reduction?
Answer from: Radiation Oncologist at Community Practice
Yes, FAST-Forward is fine after oncoplastic reduction as long as dose homogeneity criteria can be met (V105 < 5%).
Comments
Radiation Oncologist at Indiana University Health
@Sushil Beriwal, is there any thought that if a pa...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
As long as dosimetric and clinical criteria are me...
15540
15544
Sign in or Register to read more
26566
Related Questions
How do you advise patients on cardiotoxicity when they are expected to receive a low mean heart dose and low cardiac substructure doses with their radiation plan?
Do you recommend re-excision of a unifocal positive anterior margin at skin after lumpectomy in a patient with otherwise low risk breast cancer features?
When using surface image-guidance for breast radiation, how do you accommodate for changes in anatomy?
Are you comfortable combining palliative radiotherapy with capivasertib/fulvestrant?
Would you recommend MRI post surgery and pre-irradiation for patients with extensive DCIS and close margins and how would it impact your management?
When should the dissected axilla (levels I-II) be included when delivering RNI?
How do you optimally set a patient up for breast radiation therapy if you don't have access to a breast board or wing board?
What are your top takeaways in Radiation Oncology from SABCS 2024?
How do you choose between ALND and RNI in the setting of LYMPHA or S-Lympha surgery?
What are the advantages/disadvantages of using static IMRT vs VMAT when treating breast cancer?
@Sushil Beriwal, is there any thought that if a pa...
As long as dosimetric and clinical criteria are me...